This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Dimension Vista System-Loci Progesterone Assay (Prog) Assay

Starting date:
January 6, 2017
Posting date:
January 25, 2017
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Medical Devices
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-61970

Reason

Siemens has confirmed that the presence of DHEA-S (a metabolite of DHEA, a steroid hormone that may be used as part of in vitro fertilization (IVF) protocols to improve ovarian response and IVF treatment outcomes) causes falsely elevated progesterone results on the ADVIA Centaur, Dimension Vista and Immulite Systems around the clinically important decision level of approximately 1 ng/ml (3.18 nmol/l) of progesterone. This threshold is used by some IVF protocols to determine whether to proceed with fresh embryo transfer in the current cycle.

Affected products

Dimension Vista System-Loci Progesterone Assay (Prog) Assay

Lot or serial number

All lots

Model or catalog number

  • K6464

Companies

Manufacturer

Siemens Healthcare Diagnostics Inc.

500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101

Newark

19714-6101

Delaware

UNITED STATES